Merck & Co., Inc.MRKNYSE
LOADING
|||
EBITDA Over Time
Trending higher, above historical average, modest growth trend.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$25.71B
↑ 80% above average
Average (9y)
$14.26B
Historical baseline
Range
High:$25.71B
Low:$6.91B
CAGR
+8.4%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $25.71B | +272.2% |
| 2023 | $6.91B | -67.6% |
| 2022 | $21.32B | +19.1% |
| 2021 | $17.90B | +75.8% |
| 2020 | $10.18B | -10.5% |
| 2019 | $11.37B | -18.7% |
| 2018 | $13.99B | +17.1% |
| 2017 | $11.95B | +10.4% |
| 2016 | $10.82B | -13.1% |
| 2015 | $12.45B | - |